Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Patient Monitoring

PUBLISHER: Grand View Research | PRODUCT CODE: 1571467

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1571467

Non-invasive Brain Trauma Monitoring Devices Market Size, Share & Trends Analysis Report By Product (Monitoring Devices, Consumables), By End-use (Neurological Centres), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

Non-invasive Brain Trauma Monitoring Devices Market Growth & Trends:

The global non-invasive brain trauma monitoring devices market size is expected to reach USD 24.8 billion by 2030, registering to grow at a CAGR of 8.6% from 2024 to 2030 according to a new report by Grand View Research, Inc. The rising burden of Traumatic Brain Injuries (TBI) is a leading cause of neurodegenerative disorders such as Alzheimer's and Parkinson's disease. As a result, there are numerous initiatives taken at the regional and global levels to create awareness, which facilitated a heavy diagnosis rate, thus governing the growth of non-invasive brain trauma monitoring devices.

Technological advancements in this field are connected with accuracy, portability, and affordability, which are supporting the industry growth. For instance, recently available non-invasive intracranial pressure monitors, such as Transcranial Doppler (TCD), are accurate in positioning and creating a better pressure gradient and also bringing in more accuracy in the treatment.

The Minimally Invasive Surgeries (MIS) are less traumatic to patients and facilitate faster recovery with minimum complications. In minimally invasive neurological surgeries, non-invasive brain trauma monitoring devices play a critical role. Thus, the increasing volume of MIS is driving the industry's growth.

The key target population in this industry includes people above 60 years. This section of the population is at a greater risk for TBIs and their co-morbidities. The global geriatric population is on arise and is a vital driver for this industry.

Non-invasive Brain Trauma Monitoring Devices Market Report Highlights:

  • Monitoring devices that include intracranial pressure monitors, MRI scanners, CT scanners, PET scanners, EEG, and MEG held a substantial share of around 63.2% in 2023. The high costs associated with this equipment and the increasing usage of these devices governed the growth of this segment.
  • The consumables sub-segment in the product segment is anticipated to witness lucrative growth over the forecast period. The repeat purchase of consumables and regular maintenance activities are expected to spur the demand for these products.
  • The market on the basis of end-use is segmented into hospitals, neurological centers, and other settings. The hospital segment dominated the end-use segment with over 80.9% of the revenue. The greater volume of surgeries performed in hospitals contributed to its growth.
  • North America dominated the non-invasive brain trauma monitoring devices market in 2023. The advanced healthcare system, high awareness level, and well-planned reimbursement policies helped this market to grow in this region. However, Asia Pacific is anticipated to witness significant growth over the forecast period.
  • Some key players operating in this industry include Advanced Brain Monitoring, Inc.; Cadwell Industries, Inc.; Canon Medical Systems Corporation; Compumedics Ltd.; Magstim EGI; General Electric Company; Hitachi, Ltd.; Koninklijke Philips N.V.; Medtronic; Natus Medical Incorporated; NeuroLogica Corp.; NeuroWave Systems, Inc., are the key initiatives in this industry.
Show more
Product Code: GVR-1-68038-022-4

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Non-Invasive Brain Trauma Monitoring Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Non-Invasive Brain Trauma Monitoring Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Non-Invasive Brain Trauma Monitoring Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Non-Invasive Brain Trauma Monitoring Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Monitoring Devices
    • 4.3.1. Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Intra Cranial Pressure Monitor
      • 4.3.2.1. Intra Cranial Pressure Monitor Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. MRI Scanner
      • 4.3.3.1. MRI Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. CT Scanner
      • 4.3.4.1. CT Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. PET Scanner
      • 4.3.5.1. PET Scanner Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. EEG
      • 4.3.6.1. EEG Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.7. MEG
      • 4.3.7.1. MEG Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.8. Others
      • 4.3.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Consumables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Electrodes
      • 4.4.2.1. Electrodes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Sensors
      • 4.4.3.1. Sensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Fibre Optic Cables
      • 4.4.4.1. Fibre Optic Cables Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Non-Invasive Brain Trauma Monitoring Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Non-Invasive Brain Trauma Monitoring Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Neurological Centers
    • 5.4.1. Neurological Centers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Non-Invasive Brain Trauma Monitoring Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Non-Invasive Brain Trauma Monitoring Devices Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East & Africa (MEA)
    • 6.6.1. MEA Non-Invasive Brain Trauma Monitoring Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Advanced Brain Monitoring, Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. Cadwell Industries, Inc.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. Canon Medical Systems Corporations
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Compumedics Ltd.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Magstim EGI
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. General Electric Company
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Hitachi, Ltd.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Koninklijke Philips N.V.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Medtronic
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. Natus Medical Incorporated
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. NeuroLogica Corp.
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. NeuroWave Systems, Inc.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives
    • 7.4.13. Nihon Kohden Corporation
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/Strategic Initiatives
    • 7.4.14. Noraxon USA
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/Strategic Initiatives
    • 7.4.15. RAUMEDIC AG
      • 7.4.15.1. Participant's Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Recent Developments/Strategic Initiatives
    • 7.4.16. Sense Neuro
      • 7.4.16.1. Participant's Overview
      • 7.4.16.2. Financial Performance
      • 7.4.16.3. Product Benchmarking
      • 7.4.16.4. Recent Developments/Strategic Initiatives
    • 7.4.17. Siemens
      • 7.4.17.1. Participant's Overview
      • 7.4.17.2. Financial Performance
      • 7.4.17.3. Product Benchmarking
      • 7.4.17.4. Recent Developments/Strategic Initiatives
    • 7.4.18. Sophysa
      • 7.4.18.1. Participant's Overview
      • 7.4.18.2. Financial Performance
      • 7.4.18.3. Product Benchmarking
      • 7.4.18.4. Recent Developments/Strategic Initiatives
    • 7.4.19. Spiegelberg GmbH & Co. KG
      • 7.4.19.1. Participant's Overview
      • 7.4.19.2. Financial Performance
      • 7.4.19.3. Product Benchmarking
      • 7.4.19.4. Recent Developments/Strategic Initiatives
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!